NCT00612911

Cell Therapy in Dilated Cardiomyopathy: Observational Study

Cell Therapy in Dilated Cardiomyopathy: A Safety and Feasibility Study Using Autologous Bone Marrow Mononuclear Cells

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 24 (actual)
• Sponsor: Ministry of Health, Brazil · Other Government
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Using bone marrow mononuclear cell in 24 patients with Idiopathic dilated cardiomyopathy

Detailed description

Patients with Idiopathic dilated cardiomyopathy class II to IV NYHA with ejection fraction \<35% were selected for phase I clinical trial of bone marrow mononuclear cell delivery in the coronary arteries and followed for 6 months

Conditions

• Cardiomyopathy, Dilated

Interventions

Type	Name	Description
OTHER	Cell therapy	bone marrow mononuclear cell

Timeline

• Start date: 2005-02-01
• Primary completion: 2006-08-01
• Completion: 2007-08-01
• First posted: 2008-02-12
• Last updated: 2008-02-12

Locations

1 site across 1 country: Brazil